Your search returned 42 results.

Results
	1.	Comparison of cardiovascular effects of crizotinib and chemotherapy in ALK-positive advanced non-small-cell lung cancer. [electronic resource] by Wilner, Keith D Usari, Tiziana Polli, Anna Kim, Elizabeth E Producer: 20190802 In: Future oncology (London, England) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers. [electronic resource] by Miceli, Jeffrey J Wilner, Keith D Swan, Suzanne K Tensfeldt, Thomas G Producer: 20060110 In: Journal of clinical pharmacology vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Clinical implications of an analysis of pharmacokinetics of crizotinib coadministered with dexamethasone in patients with non-small cell lung cancer. [electronic resource] by Lin, Swan Nickens, Dana J Patel, Maulik Wilner, Keith D Tan, Weiwei Producer: 20200324 In: Cancer chemotherapy and pharmacology vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large-scale multinational trials (PROFILE 1005 and 1007). [electronic resource] by Ou, Sai-Hong Ignatius Tang, Yiyun Polli, Anna Wilner, Keith D Schnell, Patrick Producer: 20161226 In: Cancer medicine vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe. [electronic resource] by Huang, Kui Madison, Terri Wehler, Beatrice Tiseo, Marcello Wilner, Keith D Mo, Jingping Producer: 20210402 In: Pharmacology research & perspectives vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Systematic review and network meta-analysis of first-line therapy for advanced [electronic resource] by Franek, Jacob Cappelleri, Joseph C Larkin-Kaiser, Kelly A Wilner, Keith D Sandin, Rickard Producer: 20200128 In: Future oncology (London, England) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. [electronic resource] by Wilner, Keith D Rushing, Margaret Walden, Catherine Adler, Rebecca Eskra, James Noveck, Robert Vargas, Ramon Producer: 20030318 In: Journal of clinical pharmacology vol. 42 Availability: No items available. Save to lists Add to cart (remove)
	8.	Renal Effects of Crizotinib in Patients With ALK-Positive Advanced NSCLC. [electronic resource] by Camidge, D Ross Kim, Elizabeth E Usari, Tiziana Polli, Anna Lewis, Iona Wilner, Keith D Producer: 20200721 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Pharmacokinetics in Non-Insulin-Dependent Diabetics of the Aldose Reductase Inhibitor, Zopolrestat. [electronic resource] by Inskeep, Philip B Reed, Anne E Connolly, Ann G Wilner, Keith D Vargas, Ramon McMahon, F. Gilbert Publication details: American journal of therapeutics Feb 1995 In: American journal of therapeutics vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Clinical Implications of the Pharmacokinetics of Crizotinib in Populations of Patients with Non-Small Cell Lung Cancer. [electronic resource] by Wang, Erjian Nickens, Dana J Bello, Akintunde Khosravan, Reza Amantea, Michael Wilner, Keith D Parivar, Kourosh Tan, Weiwei Producer: 20180116 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery. [electronic resource] by Wilner, Keith D Anziano, Richard J Johnson, Arlene C Miceli, Jeffrey J Fricke, James R Titus, Cynthia K Producer: 20020513 In: Journal of clinical psychopharmacology vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model. [electronic resource] by Yamazaki, Shinji Skaptason, Judith Romero, David Vekich, Sylvia Jones, Hannah M Tan, Weiwei Wilner, Keith D Koudriakova, Tatiana Producer: 20110614 In: Drug metabolism and disposition: the biological fate of chemicals vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib. [electronic resource] by Costa, Daniel B Kobayashi, Susumu Pandya, Shuchi S Yeo, Wee-Lee Shen, Zhongzhou Tan, Weiwei Wilner, Keith D Producer: 20110715 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	CP-101,606: An NR2B-Selective NMDA Receptor Antagonist. [electronic resource] by Menniti, Frank S Shah, Ajit K Williams, Stephen A Wilner, Keith D White, W Frost Chenard, Bertrand L Publication details: CNS drug reviews Dec 1998 In: CNS drug reviews vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials. [electronic resource] by Yoneda, Ken Y Scranton, Judith R Cadogan, Michael A Tassell, Vanessa Nadanaciva, Sashi Wilner, Keith D Stollenwerk, Nicholas S Producer: 20180213 In: Clinical lung cancer vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor. [electronic resource] by Chi, Andrew S Batchelor, Tracy T Kwak, Eunice L Clark, Jeffrey W Wang, Daphne L Wilner, Keith D Louis, David N Iafrate, A John Producer: 20120531 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer. [electronic resource] by Blackhall, Fiona Kim, Dong-Wan Besse, Benjamin Nokihara, Hiroshi Han, Ji-Youn Wilner, Keith D Reisman, Arlene Iyer, Shrividya Hirsh, Vera Shaw, Alice T Producer: 20151209 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer. [electronic resource] by Flaherty, Keith T Lorusso, Patricia M Demichele, Angela Abramson, Vandana G Courtney, Rachel Randolph, Sophia S Shaik, M Naveed Wilner, Keith D O'Dwyer, Peter J Schwartz, Gary K Producer: 20120801 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers. [electronic resource] by LoRusso, Patricia M Krishnamurthi, Smitha S Rinehart, John J Nabell, Lisle M Malburg, Lisa Chapman, Paul B DePrimo, Samuel E Bentivegna, Steven Wilner, Keith D Tan, Weiwei Ricart, Alejandro D Producer: 20100622 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer. [electronic resource] by Nishio, Makoto Kim, Dong-Wan Wu, Yi-Long Nakagawa, Kazuhiko Solomon, Benjamin J Shaw, Alice T Hashigaki, Satoshi Ohki, Emiko Usari, Tiziana Paolini, Jolanda Polli, Anna Wilner, Keith D Mok, Tony Producer: 20181025 In: Cancer research and treatment vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 42 results.